Kingsview Wealth Management LLC Takes Position in Danaher Corporation $DHR

Kingsview Wealth Management LLC acquired a new position in Danaher Corporation (NYSE:DHRFree Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 11,665 shares of the conglomerate’s stock, valued at approximately $2,222,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. Meeder Asset Management Inc. acquired a new position in shares of Danaher in the 2nd quarter valued at $44,000. MidFirst Bank acquired a new stake in shares of Danaher during the 2nd quarter worth about $46,000. Bell Investment Advisors Inc purchased a new stake in Danaher in the 2nd quarter valued at about $47,000. Fiduciary Financial Advisors acquired a new position in Danaher in the second quarter valued at about $53,000. Finally, Solstein Capital LLC acquired a new position in Danaher in the second quarter valued at about $58,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on DHR. Royal Bank Of Canada boosted their price target on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. HSBC decreased their price target on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Citigroup began coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. DZ Bank assumed coverage on Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective on the stock. Finally, Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Check Out Our Latest Research Report on Danaher

Danaher Stock Performance

Shares of DHR stock opened at $216.41 on Friday. The firm has a 50 day moving average of $199.46 and a two-hundred day moving average of $192.52. The stock has a market capitalization of $152.13 billion, a PE ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the firm earned $0.77 earnings per share. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. On average, research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.